Top Section/Ad
Top Section/Ad
Most recent
First sale by sponsor Abry Partners since 2020 IPO
Cell and gene therapy company plans US expansion
More articles/Ad
More articles/Ad
More articles
-
-
String of exits mean reliable source of deal flow is at risk
-
More shares sold to undisclosed international financial company alongside total return swap
-
Rare Turkish block follows stock market recovery
-
Deal was wallcrossed over two days, launched on Thursday morning
-
Strong demand for blocks could lead to early market reopening